Editorial Staff

  • Executive Editor/VP-Special Projects:
    Jeff Hall
  • Senior Editor
    Brian McCurdy
  • Circulation and Subscriptions
    Bonnie Shannon
  • Art Director:
    Alana Balboni
  • Editorial Correspondence

  • Jeff Hall, Executive Editor/VP-Special Projects, Podiatry Today
  • HMP Communications, 83 General Warren Blvd
    Suite 100, Malvern PA 19355
  • Telephone: (800) 237-7285, ext. 214
    Fax: (610) 560-0501
  • Email: jhall@hmpcommunications.com
  • December 2006 | Volume 19 - Issue 12
    By Kristin Titko, DPM
    7,672 reads | 0 comments | 12/03/06

    3,534 reads | 0 comments | 12/03/06
        We read with interest an article recently published in Podiatry Today, “Are Orthoses Effective Against Plantar Fasciitis In The Long Run?” (see page 8, September 2006). As the study investigators referred to in this article, we cannot let the opportunity pass to clear up some misconceptions presented in this article.1 In particular, we want to correct certain statements made by Russell Volpe, DPM, and Ronald Valmassy, DPM, regarding the research undertaken in our study.     In the article, Dr. Volpe suggests that, “The fact that ort ... continue reading
    By Richard T. Bouché, DPM, Peter M. Vincent, DPM, and Katrina Sullivan, DPM
    15,781 reads | 0 comments | 12/03/06
        The sport of cycling has seen tremendous growth in the past decade. Athletes are utilizing bicycling not only as their primary sport but also as a form of cross training and rehabilitation. As a result of this growth, there has been a corresponding increase in the incidence of non-traumatic (overuse) injuries. Wilber, et. al., found 85 percent of cyclists to be suffering with one or more overuse injuries with the following distribution: neck (48.8 percent), knee (41.7 percent), groin and buttocks (36.1 percent), hand (31.1 percent) and back (30.3 percent).1 & ... continue reading
    By Kevin A. Kirby, DPM, MS
    60,271 reads | 0 comments | 12/03/06
        The world of podiatric biomechanics is very different now than when Merton Root, DPM, created the first Department of Podiatric Biomechanics at the California College of Chiropody in San Francisco in 1966.1 During those exciting early years of development within the new subspecialty of “podiatric biomechanics,” Dr. Root and his podiatric colleagues created a classification system, based on the subtalar joint (STJ) neutral position, that remains to this day the most complete method by which to classify the structure of the foot and lower extremity.1,2 ... continue reading
    By Michael S. Downey, DPM, FACFAS
    33,244 reads | 0 comments | 12/03/06
         Charcot osteoarthropathy remains a chronic, progressive and destructive process that often affects the bony architecture and joints of the foot and ankle, primarily in patients with diabetic peripheral neuropathy. Despite advances in the diagnosis and management of this condition, the deformity continues to be associated with a high incidence of recurrence, treatment failure and resultant morbidity. If left untreated, Charcot foot predictably leads to deformity, ulceration, infection and amputation.      The mainstays of treatment for the Charcot foot hav ... continue reading
    By Jared Wilkinson, DPM, Michael Palladino, DPM, and Peter Blume, DPM
    24,192 reads | 0 comments | 12/03/06
          As the diabetic population continues to swell worldwide, there has also been an increased occurrence of various cutaneous manifestations associated with the disease. Researchers have reported a greater than 30 percent incidence of these disorders and they have been found in up to 70 percent of all patients with diabetes at some point during the course of their illness.1-5 Another problematic statistic for the diabetic population is the fact that 15 percent of all people with diabetes will experience at least one ulceration during their lifetime.6 ... continue reading
    By Brian McCurdy, Senior Editor
    12,763 reads | 0 comments | 12/03/06
        Podiatrists often face the challenge of patients with diabetes who are unaware they have the disease. A new survey commissioned by the American Podiatric Medical Association (APMA) discovers that such problems are particularly challenging among Hispanic-American patients, finding that a significant percentage of this patient population exhibits the warning signs of the disease. ... continue reading
    By Harvey Lemont, DPM
    118,678 reads | 0 comments | 12/03/06
          In general, plantar warts are very difficult to treat and pose a certain challenge to physicians and their patients. Both physicians and patients should not be discouraged by an initial poor result. With proper communication between the doctor and patient, one can achieve realistic outcomes.       Too often, doctors downplay treatment, only to be reproached by a frustrated and angry patient who received unrealistic expectations. For example, the treatment of chemosurgery using acids may take as long as six weeks. If the warts resolve in three weeks, the ... continue reading
    By Jeff Hall, Executive Editor
    1,748 reads | 0 comments | 12/03/06
        How bad have things gotten at the Food and Drug Administration (FDA)? When you consider some of the recent reports and developments over the past few months, it is clear that the FDA has significant credibility issues.     In June, a report by U.S. Rep. Henry A. Waxman revealed some eye-opening trends in FDA enforcement actions in recent years. According to the report, which reportedly involved an investigation and review of copious internal agency enforcement documentation, there was a greater than 50 percent decrease from 2000 to 2005 in the number of FDA ... continue reading
    By Gary “Dock” Dockery, DPM, FACFAS
    76,386 reads | 0 comments | 12/03/06
          A 29-year-old Caucasian female patient presented in consultation in the foot and ankle clinic regarding a six-week history of erythematous vesicles and papules on the soles. She reported intense pruritus. Her primary care physician told her that she had a case of “athlete’s feet” and that she should use an over-the-counter (OTC) antifungal cream. After two weeks of treatment with antifungal cream, the patient had no improvement. ... continue reading